Heparin-induced thrombocytopenia: Further evidence for a unique immune response

Blood

Volumn 120, Issue 20, 2012, Pages 4238-4245

  Pötschke, Christian ^a   Selleng, Sixten ^a   Bröker, Barbara M ^a   Greinacher, Andreas ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; DIPHTHERIA TOXIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; TETANUS TOXOID;

ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE ACTIVATION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POLYCLONAL ACTIVATION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84869780345     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-419424     Document Type: Article

References (62)

1. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1998;79(1):1-7. (Pubitemid 28037046)
2. Warkentin TE, Sheppard JA, Moore JC, Cook RJ, Kelton JG. Studies of the immune response in heparin-induced thrombocytopenia. Blood. 2009;113(20):4963- 4969.
3. Greinacher A, Kohlmann T, Strobel U, Sheppard JA, Warkentin TE. The temporal profile of the anti-PF4/heparin immune response. Blood. 2009;113(20):4970-4976.
4. Lubenow N, Hinz P, Thomaschewski S, et al. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. Blood. 2010;115(9):1797-1803.
5. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000;96(5):1703-1708. (Pubitemid 30661052)
6. Greinacher A. Heparin-induced thrombocytopenia: frequency and pathogenesis. Pathophysiol Haemost Thromb. 2006;35(1-2):37-45.
7. Krauel K, Potschke C, Weber C, et al. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood. 2011;117(4):1370-1378.
8. Greinacher A, Althaus K, Krauel K, Selleng S. Heparin-induced thrombocytopenia. Hamostaseologie. 2010;30(1):17-18, 20-18.
9. Warkentin TE. HIT paradigms and paradoxes. J Thromb Haemost. 2011;9(Suppl 1):105-117.
10. Jeske WP, Jay AM, Haas S, Walenga JM. Heparin-induced thrombocytopenic potential of GAG and non-GAG-based antithrombotic agents. Clin Appl Thromb Hemost. 1999;5(Suppl 1):S56-S62. (Pubitemid 29529682)
11. Socher I, Kroll H, Jorks S, Santoso S, Sachs UJ. Heparin-independent activation of platelets by heparin-induced thrombocytopenia antibodies: a common occurrence. J Thromb Haemost. 2008;6(1):197-200.
12. Warkentin TE. HITlights: a career perspective on heparin-induced thrombocytopenia. Am J Hematol. 2012;87(Suppl 1):S92-S99.
13. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med. 2001;135(7):502-506. (Pubitemid 32923567)
14. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286-1292. (Pubitemid 32372963)
15. Bocsi J, Richter M, Hambsch J, et al. Transient Th1/Th2 disbalance indicates postoperative effusions and edema after cardiopulmonary bypass in children. Cytometry A. 2006;69(3):165-168.
16. Hill GE. The inflammatory response to cardiopulmonary bypass. Int Anesthesiol Clin. 1996;34(2):95-108. (Pubitemid 26194915)
17. Herskowitz A, Mangano DT. Inflammatory cascade. A final common pathway for perioperative injury? Anesthesiology. 1996;85(5):957-960. (Pubitemid 26378278)
18. Diegeler A, Doll N, Rauch T, et al. Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass. Circulation. 2000;102(19 Suppl 3):III95-100.
19. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002;298(5601):2199-2202. (Pubitemid 35471246)
20. Traggiai E, Puzone R, Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine. 2003;21(Suppl 2):S35-S37. (Pubitemid 36588647)
21. Lanzavecchia A, Bernasconi N, Traggiai E, Ruprecht CR, Corti D, Sallusto F. Understanding and making use of human memory B cells. Immunol Rev. 2006;211:303-309. (Pubitemid 43882981)
22. Lanzavecchia A, Sallusto F. Human B cell memory. Curr Opin Immunol. 2009;21(3):298-304.
23. Selleng S, Malowsky B, Itterman T, et al. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery. Am Heart J. 2010;160(2):362-369.
24. Selleng S, Malowsky B, Strobel U, et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost. 2010;8(1):30-36.
25. Selleng S, Schreier N, Wollert HG, Greinacher A. The diagnostic value of the anti-PF4/heparin immunoassay high-dose heparin confirmatory test in cardiac surgery patients. Anesth Analg. 2011;112(4):774-776.
26. Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Eur J Haematol. 2006;76(5):420-426.
27. Pötzsch B, Klovekorn WP, Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N Engl J Med. 2000;343(7):515. (Pubitemid 30646499)
28. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2006;355(8):809-817.
29. Greinacher A, Gopinadhan M, Gunther JU, et al. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Arterioscler Thromb Vasc Biol. 2006;26(10):2386-2393. (Pubitemid 44465738)
30. Pruthi RK, Daniels PR, Nambudiri GS, Warkentin TE. Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery 'spontaneous' HIT. J Thromb Haemost. 2009;7(3):499-501.
31. Perrin J, Barraud D, Toussaint-Hacquard M, Bollaert PE, Lecompte T. Rapid onset heparin-induced thrombocytopenis (HIT) without history of heparin exposure: A new case of so-called 'spontaneous' HIT. Thromb Haemost. 2012;107(4):795-797.
32. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759-765.
33. Woods KM, Pope MR, Hoffman SM, Fleming SD. CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent. J Immunol. 2011;186(3):1755-1762.
34. Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity. 2007;26(2):205-213. (Pubitemid 46329436)
35. Greinacher A, Holtfreter B, Krauel K, et al. Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease. Blood. 2011;118(5):1395-1401.
36. Gruel Y, Pouplard C. Post-operative platelet count profile: the most reliable tool for identifying patients with true heparin-induced thrombocypenia after cardiac surgery. J Thromb Haemost. 2010;8(1):27-29.
37. Pouplard C, May MA, Regina S, Marchand M, Fusciardi J, Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol. 2005;128(6):837-841. (Pubitemid 40444878)
38. Lante W, Franke A, Weinhold C, Markewitz A. Immunoglobulin levels and lymphocyte subsets following cardiac operations: further evidence for a T-helper cell shifting. Thorac Cardiovasc Surg. 2005;53(1):16-22. (Pubitemid 40288937)
39. van Velzen-Blad H, Dijkstra YJ, Schurink GA, et al. Cardiopulmonary bypass and host defense functions in human beings: I. Serum levels and role of immunoglobulins and complement in phagocytosis. Ann Thorac Surg. 1985;39(3):207-211. (Pubitemid 15131332)
40. Radbruch A, Muehlinghaus G, Luger EO, et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol. 2006;6(10):741-750. (Pubitemid 44453460)
41. Selleng K, Schutt A, Selleng S, Warkentin TE, Greinacher A. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens. Transfusion. 2010;50(1):32-39.
42. Suvarna S, Qi R, Hollingsworth JW, Arepally GM. Platelet factor 4-heparin complexes trigger immune responses independently of the MyD88 pathway. Br J Haematol. 2008;142(4):671-673. (Pubitemid 352020221)
43. Hensler T, Hecker H, Heeg K, et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun. 1997;65(6):2283-2291. (Pubitemid 27237311)
44. Grundmann U, Rensing H, Adams HA, et al. Endotoxin desensitization of human mononuclear cells after cardiopulmonary bypass: role of humoral factors. Anesthesiology. 2000;93(2):359-369. (Pubitemid 30620309)
45. Franke A, Lante W, Kollig E, Koeller M, Schinkel C, Markewitz A. Exogenous IL-12 and its effect on TH1/TH2 cell activity after cardiac surgery. Shock. 2009;32(4):366-373.
46. Franke A, Lante W, Kurig E, Zoller LG, Weinhold C, Markewitz A. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? Eur J Cardiothorac Surg. 2006;30(1):64-71. (Pubitemid 43850306)
47. DiPiro JT, Howdieshell TR, Hamilton RG, Mansberger AR Jr. Immunoglobulin E and eosinophil counts are increased after sepsis in trauma patients. Crit Care Med. 1998;26(3):465-469. (Pubitemid 28141480)
48. Chu VT, Frohlich A, Steinhauser G, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011;12(2):151-159.
49. Winter O, Moser K, Mohr E, et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood. 2010;116(11):1867- 1875.
50. Pouplard C, Cornillet-Lefebvre P, Attaoua R, et al. Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia. Thromb Res. 2012;129(4):465-469.
51. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 2008;320(5874):373-376. (Pubitemid 351555659)
52. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313(5787):670-673. (Pubitemid 44201145)
53. Nimmerjahn F, Ravetch JV. The anti-inflammatory activity of IgG: the intravenous IgG paradox. J Exp Med. 2007;204(1):11-15. (Pubitemid 46148750)
54. Sze DM, Toellner KM, Garcia de Vinuesa C, Taylor DR, MacLennan IC. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med. 2000;192(6):813-821.
55. Ambrosch F, Balda BR, Dietze H, et al, eds. Infektionsschutz durch Impfprophylaxe: Tetanus. Bruchsal, Germany: Storck Medien & Verlag KG; 1999.
56. Schröder JP, Kuhlmann WD. [Tetanus immunity in men and women in the Federal Republic of Germany]. Immun Infekt. 1991;19(1):14-17.
57. World Health Organization. Position paper on Diphtheria vaccine. Weekly Epidemiological Record. 2006;81:21-32. Available from: http://www.who.int/ immunization/wer8103Diphtheria-Jan06-position-paper.pdf. Accessed June 1, 2011.
58. Xiang Z, Cutler AJ, Brownlie RJ, et al. Fcgamma-RIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol. 2007;8(4):419-429. (Pubitemid 46745417)
59. Moser K, Muehlinghaus G, Manz R, et al. Long-lived plasma cells in immunity and immunopathology. Immunol Lett. 2006;103(2):83-85. (Pubitemid 43162920)
60. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol. 2005;23:367-386. (Pubitemid 40563174)
61. Tarlinton D, Radbruch A, Hiepe F, Dorner T. Plasma cell differentiation and survival. Curr Opin Immunol. 2008;20(2):162-169.
62. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357(19):1903-1915. (Pubitemid 350074686)